Clinical and Experimental Rheumatology is a bi-monthly international peer-reviewed journal which has been covering all clinical, experimental and translational aspects of musculoskeletal, arthritic and connective tissue diseases since 1983.
In addition to regular issues, it also publishes a number of annual supplements dedicated to the following diseases:
Articles submitted on these topics are processed with the same peer-review criteria as those published in the regular issues. Once accepted, they are published ahead-of-print online, and subsequently included in the correspondent supplement issue, unless otherwise expressly requested by the Authors.
Articles published in the supplements share the same citation coverage and impact factor as the main journal (PubMed, Scopus, Science Citation Index, etc.).
Stefano Bombardieri, MD
Letter to Editor Rheumatology: Commentaries and Controversies (LER) has been an online forum for a stronger voice and a wider audience for critical and dissenting views in rheumatology and related disciplines. It has joined forces with Clinical and Experimental Rheumatology to achieve the deserved wider audience.
A page charge of €100.00 will be assessed for all articles published. Instructions for payment will be sent to authors along with the proofs. There is no charge for solicited articles.
A unique feature of Clinical and Experimental Rheumatology - our five annual supplements.
The hottest topics in clinical rheumatology discussed annually by the leading experts in the field.
Edited by Theodore Pincus, appearing annually since 1999
A unique regular supplement devoted to Behçet's Disease, familial Mediterranean fever and other Autoinflammatory conditions.
Edited by H. Yazici and E. Ben-Chetrit, appearing annually since 2001
Inaugurated in 2003, this supplement is devoted to the heterogeneous and overlapping spectrum of clinical syndromes known as vasculitis.
Edited in 2003-2004 by G.S. Hoffman, L.H. Calabrese and C.A. Langford
From 2005 edited by W.G. Gross, L. Guillevin and C. Salvarani
Starting in 2009 a new annual supplement entirely devoted to this condition.
Edited in 2009/2012 by P.C. Clements, J.R. Seibold and M. Matucci Cerinic
From 2015 edited by S. Bombardieri
Since 2009 a regular supplement devoted to the latest aspects in the management of fibromyalgia.
Starting in 2018 a new annual supplement to shed lights on an emerging protagonist of the systemic autoimmune diseases.
Guest Editors: M. Bombardieri, S. De Vita, T. Dörner, M. Ramos-Casals, A.G. Tzioufas